Alpine Immune Sciences Inc expected to post a loss of 37 cents a share - Earnings Preview

Alpine Immune Sciences

07/08/2023 12:41

* Alpine Immune Sciences Inc  ALPN.OQ   ALPN.O  is expected
to show a rise in quarterly revenue when it reports  results on
August 9 (estimated). 
    * The Seattle Washington-based  company is expected to
report  a
67.2% increase in revenue to $8.85 million from $5.29 million a
year ago, according to the mean estimate from 4 analysts, based
on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Alpine Immune
Sciences
Inc is for a loss of 37 cents per share. 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 6 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Alpine
Immune
Sciences Inc is $16​, above​ its last closing price of $13.98.
​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Mar. 31 2023  -0.37       -0.37      -0.28     Beat    24.4
 Dec. 31 2023              -0.27      -0.41     Missed  -53
 Sep. 30 2022  -0.02       -0.10      -0.42     Missed  -309.8
                                                        ​
 Jun. 30 2022  -0.46       -0.39      -0.60     Missed  -52.9
 ​​Mar.        -0.27       -0.19      -0.25     Missed  -33.3
 31 2022                                                
 Dec. 31 2021  -0.43       -0.30      -0.52     Missed  -70.5​
 Sep. 30 2021  0.17        0.01       -0.55     Missed  -11,10
                                                        0
 Jun. 30 2021  -0.37       -0.40      -0.46     Missed  -16.2
 This summary was machine generated August 7 at 11:41 GMT.  All
figures in US dollars  unless otherwise stated